​Following media reports on 10 March that GUINNESS had reached a resolution with the National Agency for Food and Drug Administration (NAFDAC) which had on 9 November slammed a N1 billion ($5 million) as administrative charges for various clandestine violations of NAFDAC rules, regulations and enactments over a long period of time, we reached out to the Brewer’s management to confirm the story.
Vetiva provides clients with independent and unbiased access to analysis and opinion. We keep our clients on the cutting edge of market information and provide up to date market intelligence on quoted companies. Our services allow brokers, investment firms, and asset managers focus their energies on developing investment strategies and client relationships.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.